Genentech's P2P Acquisition

Genentech raised a round of funding on March 27, 2009. Investors include Roche Holding.

Genentech is a biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions.…

Articles about Genentech's P2P Acquisition: